PT-141 (Bremelanotide)
Melanocortin receptor agonist studied for its role in libido and sexual health in both men and women.
Studied Benefits
- Studied for sexual desire (HSDD trials)
- Central arousal-pathway research
- Melanocortin MC3R/MC4R activation
- FDA-approved as Vyleesi (specific indication)
Research Use Only
This compound is intended for laboratory and research purposes only. It is not approved for human consumption and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional.
Independently Reviewed
We only list vendors that provide third-party, batch-specific COAs.
Ignite Peptides
Buy Direct from Ignite Peptides →Peak Lab Peptides
Buy Direct from Peak Lab Peptides →Main Peptides
Buy Direct from Main Peptides →Affiliate disclosure: links above are affiliate partnerships. We may earn a commission at no cost to you.
Related in Longevity & Wellness
SS-31 (Elamipretide)
Mitochondria-targeted tetrapeptide that binds directly to cardiolipin in the inner mitochondrial membrane, stabilizing membrane structure and reducing oxidative stress at the site of energy production.
View product →
SLU-PP-332
Synthetic pan-agonist of the estrogen-related receptor family (ERRα/β/γ) developed at Saint Louis University, studied for activating exercise-associated transcriptional programs — mitochondrial biogenesis, fatty-acid oxidation, and oxidative metabolism — without physical exertion.
View product →
Make this protocol yours
The Engine reads your biometrics and personalizes dosing, timing, and stacking — free at engine.auraprotocols.com.
Try the Engine →